Cargando…
The Effects of Celecoxib or Naproxen on Blood Pressure in Pediatric Patients with Juvenile Idiopathic Arthritis
BACKGROUND: Selective and nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) are indicated for the treatment of juvenile idiopathic arthritis (JIA). However, the effect of NSAIDs on blood pressure (BP) in children has not been rigorously examined. METHODS: In this randomized, double-blind, m...
Autores principales: | Falkner, B, Berger, M, Bhadra Brown, P, Iorga, D, Nickeson, RW, Zemel, L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425196/ https://www.ncbi.nlm.nih.gov/pubmed/25987857 http://dx.doi.org/10.4137/CMPed.s20720 |
Ejemplares similares
-
Efficacy and tolerability of celecoxib and naproxen versus placebo in Hispanic patients with knee osteoarthritis
por: Essex, Margaret Noyes, et al.
Publicado: (2014) -
Early onset pauciarticular arthritis is the major risk factor for naproxen-induced pseudoporphyria in juvenile idiopathic arthritis
por: Schäd, Susanne G, et al.
Publicado: (2007) -
The Suspension of Treatments in ADAPT: Concerns beyond the Cardiovascular Safety of Celecoxib or Naproxen
por: Breitner, John C. S, et al.
Publicado: (2006) -
A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis
por: Lovell, Daniel J., et al.
Publicado: (2018) -
Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the phase 4 registry
por: Sobel, Rachel E, et al.
Publicado: (2014)